Mr. DeVinney joined AxoGen Corporation in April 2007. He has served as Vice President of Clinical and Translational Sciences for AxoGen, Inc. since January 2014. Prior to his current role, he served as Director of Clinical and Translational Sciences for AxoGen, Inc. from November 2011 to January 2014 and for AxoGen Corporation from April 2007 to January 2014. Erick has over fifteen years of experience in the successful planning and management of clinical trials. He has diverse background including research at a large academic facility and management of clinical operations for a medical device and pharmaceutical company. Erick has been involved in clinical research at Medical College of Virginia Hospitals, National Clinical Research, PRA International, and Angiotech. He has been involved in the successful submission of eight IDE or NDA applications as well as numerous 510(k)s. He has a BS in Chemistry from Virginia Commonwealth University.